Abstract
We describe a previously not recognized nonsense mutation in exon 10 of the ALS2 gene in two sibs with infantile-onset ascending spastic paralysis. The mutation predicts chain termination at amino-acid position 715 of the gene product ALSIN (p.Gln715X). The sibs’ parents are descendants of a common ancestor who lived in the northern Netherlands during the eighteenth century. This is the first ALS2 mutation detected in northwestern Europeans. The findings emphasize that mutations in ALS2 also need to be considered in patients from northwestern Europe with early-onset spastic paralysis and amyotrophic or primary lateral sclerosis.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hadano S, Hand CK, Osuga H et al: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001; 29: 166–173.
Yang Y, Hentati A, Deng HX et al: The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29: 160–165.
Eymard-Pierre E, Lesca G, Dollet S et al: Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet 2002; 71: 518–527.
Gros-Louis F, Meijer IA, Hand CK et al: An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann Neurol 2003; 53: 144–145.
Pringle CE, Hudson AJ, Munoz DG et al: Primary lateral sclerosis, clinical features, neuropathology and diagnostic criteria. Brain 1992; 115: 495–520.
Lesca G, Eymard-Pierre E, Santorelli FM et al: Infantile ascendine hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology 2003; 60: 674–682.
Ohtsubo M, Kai R, Furuno N et al: Isolation and characterization of the active cDNA of the human cell cycle gene (RCC1) involved in the regulation of onset of chromosome condensation. Genes Dev 1987; 1: 585–593.
Schmidt A, Hall A : Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002; 16: 1587–1609.
Otomo A, Hadano S, Okada T et al: ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet 2003; 12: 1671–1687.
Eymard-Pierre E, Yamanaka K, Haeussler M et al: Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis. Ann Neurol 2006; 59: 976–980.
Kress JA, Kühnlein P, Winter P et al: Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol 2005; 58: 800–803.
Panzeri C, De Palma C, Martinuzzi A et al: The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain 2006; 129: 1710–1719.
Devon RS, Helm JR, Rouleau GA et al: The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin Genet 2003; 64: 210–215.
Hadano S, Kunita R, Otomo A et al: Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration. Neurochem Int 2007; 51: 74–84.
Topp J, Gray NW, Gerard RD et al: Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J Biol Chem 2004; 23: 24612–24623.
Devon RS, Schwab C, Topp JD et al: Cross-species characterization of the ALS2 gene and analysis of its pattern of expression in development and adulthood. Neurobiol Dis 2005; 18: 243–257.
Antonarakis SE, The Nomenclature Working Group: Recommendations for a nomenclature system for human gene mutations. Hum Mut 1998; 11: 1–3.
Acknowledgements
We thank Jackie Senior and Mary Kay Steen-Müller for editing the text and Jan J Hoetjes for his extensive genealogy work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verschuuren-Bemelmans, C., Winter, P., Sival, D. et al. Novel homozygous ALS2 nonsense mutation (p.Gln715X) in sibs with infantile-onset ascending spastic paralysis: the first cases from northwestern Europe. Eur J Hum Genet 16, 1407–1411 (2008). https://doi.org/10.1038/ejhg.2008.108
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2008.108
Keywords
This article is cited by
-
Clinical features and molecular genetic investigation of infantile-onset ascending hereditary spastic paralysis (IAHSP) in two Chinese siblings caused by a novel splice site ALS2 variation
BMC Medical Genomics (2024)
-
ALS2-related disorders in Spanish children: a severely affected case of infantile ascending spastic paraplegia due to homozygous R704X mutation
Neurological Sciences (2022)
-
ALS2-related disorders in Spanish children
Neurological Sciences (2021)
-
Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant
Neurological Sciences (2018)
-
Maternal uniparental heterodisomy with partial isodisomy of a chromosome 2 carrying a splice acceptor site mutation (IVS9–2A>T) in ALS2 causes infantile-onset ascending spastic paralysis (IAHSP)
neurogenetics (2009)
